The Board of Directors of Sapporo Clinical Laboratory Inc. has authorized a buyback plan on May 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
991 JPY | -1.59% | -8.33% | -1.00% |
1st Jan change | Capi. | |
---|---|---|
-1.00% | 21.58M | |
-6.12% | 9.26B | |
+31.94% | 1.34B | |
-7.54% | 367M | |
+2.64% | 271M | |
+12.22% | 231M | |
-39.42% | 93.41M | |
-9.17% | 87.11M | |
+19.44% | 59.57M |
- Stock Market
- Equities
- 9776 Stock
- News Sapporo Clinical Laboratory Inc.
- Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.